Navigation Links
New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management
Date:3/29/2009

ased when TRILIPIX is used with a statin.

"More comprehensive treatment is often needed in certain patients with mixed dyslipidemia to help reach targets for all three key lipids," said Eli Roth, M.D., University of Cincinnati College of Medicine, and Sterling Research Group, Cincinnati, Ohio. "The results from this study are encouraging because TRILIPIX combined with the lowest available dose of rosuvastatin calcium improved LDL cholesterol, HDL cholesterol and triglycerides."

More than 100 million American adults have lipid problems, and 35 percent reported being treated with lipid-altering medications. Of the patients being treated, fewer than one in three (30 percent) were at recommended levels for all three key lipids. Treatment guidelines endorsed by the National Cholesterol Education Panel, the American College of Cardiology and the American Heart Association have called for more aggressive management of lipids, including a lower LDL goal for many patients, as well as more aggressive management of HDL and triglycerides.

About the Study Design

The efficacy and safety of TRILIPIX in combination with rosuvastatin calcium was evaluated in a multicenter, randomized, double-blind, parallel group, 12-week, Phase III study of 760 patients with mixed dyslipidemia. Patients included in the study had multiple lipid problems, with an LDL greater than or equal to 130 mg/dL, triglycerides greater than or equal to 150 mg/dL and HDL less than 40 mg/dL for men and less than 50 mg/dL for women.

Following a six-week period in which patients were not allowed to take cholesterol medications, patients were randomized to receive TRILIPIX 135 mg alone, rosuvastatin calcium 5 mg alone or TRILIPIX 135 mg in combination with rosuvastatin calcium 5 mg. The primary efficacy comparisons were mean percent changes in triglycerides and HDL with the combination versus rosuvastatin calcium al
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
2. FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
3. Studies Show Combination Laser Therapy Effective At Clearing Acne, Reducing Oil Production
4. New Study Using Combination of Bioengineered Skin and Stem Cells Shows Promise in Treatment of Non-Healing Wounds
5. Novexels NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)
6. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
7. Phase 1 Trial of Quadramet in Combination with Velcade Shows Positive Results
8. Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass
9. Access Pharmaceuticals Presents new Combination Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
10. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
11. InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets  has ... Pipeline Insight 2014" report to their offering. ... is one of the largest segments of pharmaceuticals industry. The ... while the available therapies were unable to meet the market ... market for CNS disorder, especially over the past two decades. ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Research and Development Trend Forecast of Pharmaceutical Equipment ... Research and Development Trend Forecast of ... 2014-2018 mainly analyzes China,s pharmaceutical ... supply & demand, competition landscape, and business performance of ...
(Date:8/29/2014)... , August 29, 2014 ... Market by Product & Services (Equipment, Reagent, Primer, ... Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, ... MarketsandMarkets, the global Oligonucleotide Synthesis Market is expected ... Million in 2014, growing at a CAGR of ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
... Compare Genous vs. Drug-Eluting and Bare ... ... in the,randomized TRIAS (TRI-stent Adjudication Study) trial of OrbusNeich,s,Genous Bio-engineered R ... April, according to Robbert de Winter, M.D., Ph.D.,principal investigator and director ...
... 16 Protocol Driven Healthcare,Inc. (PDHI) today ... Hallmark Insights to provide fully integrated incentive ... ConXus health improvement platform. ConXus Rewards ... points earned by participants completing activities within ...
Cached Medicine Technology:Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) 2PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs 2
(Date:8/31/2014)... August 31, 2014 Healthy Grid ... cavities. Loloz lollipops will use herbs to fight ... hard candies will also fight bacteria while stimulating saliva production. ... together,” said Andrew Clapp of Healthy Grid. “Even though personal ... can always use a little more prevention. Cavities are painful ...
(Date:8/31/2014)... CO (PRWEB) August 31, 2014 ... released award winning, “Simplicity & Sophistication: Short Stories ... written and narrated by Dr. James W. Jackson author, ... Sophistication,” Dr. Jackson compresses his vast volume ... four decades into over 150 countries on behalf of ...
(Date:8/31/2014)... 2014: Renal denervation seems to be more successful at ... it includes accessory renal arteries, according to research presented ... Germany. , Dr Schmiedel said: "More than one billion ... as blood pressure (BP) greater than 140/90 mmHg. Up ... and are unable to reduce BP below 140/90 mmHg ...
(Date:8/30/2014)... Sunday 31 August 2014: Local anaesthetic is as safe ... general anaesthetic, according to results of the FRANCE 2 ... Chopard from France. , Dr Chopard said: "Numerous studies ... for patients with severe symptomatic aortic stenosis who are ... aortic valve replacement. The number of TAVI procedures in ...
(Date:8/30/2014)... Not only is USHEALTH Advisors now on pace ... its highest level of late-summer sales, including a new company ... to set a new record in 2014,” stated USHEALTH Advisors ... in both weekly annualized volume and the amount of writing ... August, we saw even more of our agents enjoying tremendous ...
Breaking Medicine News(10 mins):Health News:Healthy Grid: Fight Cavities With Sweet Treats 2Health News:Healthy Grid: Fight Cavities With Sweet Treats 3Health News:Brook Forest Voices Announces End of Summer Release! Dr. James Jackson’s, “Simplicity & Sophistication” Audiobook 2Health News:Renal denervation more successful when it includes accessory arteries 2Health News:Local anesthetic for TAVI as safe and effective as general anesthetic 2Health News:USHEALTH Advisors, LLC Continues Its Record-Setting Sales Pace 2
... For his dedication to advancing the diversity of doctoral-level ... the American Association for the Advancement of Science (AAAS) ... DeSimonewho serves as both the Chancellor,s Eminent Professor of ... Hill (UNC), and as the William R. Kenan, Jr. ...
... (BWH) was selected by the Centers for Medicare & ... a demonstration project that promotes appropriate utilization of advanced ... was selected as a convener under the Medical Imaging ... Medical Center-Physician Hospital Organization; University of Wisconsin Hospital Foundation, ...
... Amanda Gardner HealthDay Reporter , WEDNESDAY, Feb. 16 ... state-of-the-nation,s health report and the news is mixed, with life ... On the positive side, life expectancy was up slightly ... beginning of the decade. And while women are still ...
... the unpredictable economy, nearly three-quarters (73%) of New Jersey ... globally is important to jobs and incomes in the ... Research!America. The poll data will be released today at ... research and development (R&D) experts and New Jersey business, ...
... (HealthDay News) -- Americans living in parts of Appalachia ... active in their free time, according to federal government ... least likely to be physically active during leisure time ... inactivity rates are 29.2 percent or greater for more ...
... , WEDNESDAY, Feb. 16 (HealthDay News) -- Many American parents ... and cold medicines to their kids despite U.S. Food and ... In response to research linking over-the-counter (or OTC) cough and ... ages 2 years and younger, the FDA said in 2008 ...
Cached Medicine News:Health News:2010 AAAS Mentor Award goes to Dr. Joseph M. DeSimone of the University of North Carolina at Chapel Hill, and North Carolina State University 2Health News:2010 AAAS Mentor Award goes to Dr. Joseph M. DeSimone of the University of North Carolina at Chapel Hill, and North Carolina State University 3Health News:2010 AAAS Mentor Award goes to Dr. Joseph M. DeSimone of the University of North Carolina at Chapel Hill, and North Carolina State University 4Health News:Brigham and Women's Hospital selected to participate in Medicare imaging demonstration project 2Health News:Brigham and Women's Hospital selected to participate in Medicare imaging demonstration project 3Health News:America's Health a Mixed Bag: Report 2Health News:America's Health a Mixed Bag: Report 3Health News:Most New Jersey residents see global health as critical to state's economy 2Health News:Most New Jersey residents see global health as critical to state's economy 3Health News:Appalachia, the South Home to Least-Active Americans: CDC 2Health News:Parents Still Giving Cough, Cold Meds to Kids Under 2: Poll 2
... A product you can trust its ... perform retinal, cataract, and glaucoma therapy ... III Combi is the optimal system ... and combined iridotomy. The push of ...
... YAG III is the new disruption ... in particular for applications in posterior ... the YAG laser is also used ... IOL polishing. It's another milestone in ...
... is a top quality Carl Zeiss Meditec ... vision defects even safer, more patient-friendly and ... work platform are oriented towards increasing efficiency, ... recovery of vision. Key factors here are ...
An aid for advancing a pacemaker lead through the subcutaneous tissue of the chest wall to the pacemaker pocket....
Medicine Products: